Evidence map›Paper›PMID 34179049›Full record

ArticleFrontiers in medicine2021

Exploring the Protective Effects and Mechanism of Crocetin From Saffron Against NAFLD by Network Pharmacology and Experimental Validation.

Zijin Xu, Susu Lin, Junjie Gong, Peishi Feng, Yifeng Cao, Qiaoqiao Li, Yuli Jiang, Ya You, Yingpeng Tong, Ping Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Exploring the Protective Effect and Mechanism ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Zijin XuCollege of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China.
Susu LinCollege of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China.
Junjie GongCollege of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China.
Peishi FengCollege of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China.
Yifeng CaoCollege of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China.
Qiaoqiao LiCollege of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China.
Yuli JiangCollege of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China.
Ya YouCollege of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China.
Yingpeng TongSchool of Life Sciences, Taizhou University, Taizhou, China.
Ping WangCollege of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China.
Zhejiang University of Technology · CNTaizhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

crocetinHO-1NAFLDnetwork pharmacologyNrf2saffron

Identifiers

PMID34179049
PMCPMC8219931
OpenAlexW3168975626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.